[HTML][HTML] Molecular and circulating biomarkers in patients with glioblastoma

N Senhaji, A Squalli Houssaini, S Lamrabet… - International Journal of …, 2022‏ - mdpi.com
Glioblastoma is the most aggressive malignant tumor of the central nervous system with a
low survival rate. The difficulty of obtaining this tumor material represents a major limitation …

Adult type diffuse gliomas in the new 2021 WHO Classification

M Antonelli, PL Poliani - Pathologica, 2022‏ - pmc.ncbi.nlm.nih.gov
Adult-type diffuse gliomas represent a group of highly infiltrative central nervous system
tumors with a prognosis that significantly varies depending on the specific subtype and …

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

H Arita, K Yamasaki, Y Matsushita, T Nakamura… - Acta neuropathologica …, 2016‏ - Springer
The prognostic impact of TERT mutations has been controversial in IDH-wild tumors,
particularly in glioblastomas (GBM). The controversy may be attributable to presence of …

Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity

A Korshunov, D Capper, D Reuss, D Schrimpf… - Acta …, 2016‏ - Springer
In contrast to the relative morphological uniformity of histone H3 K27-mutant high-grade
gliomas, H3 G34-mutant tumors present as a histopathologically heterogeneous group of …

Effective reprogramming of patient-derived M2-polarized glioblastoma-associated microglia/macrophages by treatment with GW2580

V Fermi, R Warta, A Wöllner, C Lotsch… - Clinical Cancer …, 2023‏ - aacrjournals.org
Purpose: Targeting immunosuppressive and pro-tumorigenic glioblastoma (GBM)-
associated macrophages and microglial cells (GAM) has great potential to improve patient …

[HTML][HTML] Beyond IDH-mutation: emerging molecular diagnostic and prognostic features in adult diffuse gliomas

K Mirchia, TE Richardson - Cancers, 2020‏ - mdpi.com
Diffuse gliomas are among the most common adult central nervous system tumors with an
annual incidence of more than 16,000 cases in the United States. Until very recently, the …

Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype …

PJ Cimino, M Zager, L McFerrin, HG Wirsching… - Acta neuropathologica …, 2017‏ - Springer
Recent updating of the World Health Organization (WHO) classification of central nervous
system (CNS) tumors in 2016 demonstrates the first organized effort to restructure brain …

Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early

M Morelli, F Lessi, S Barachini, R Liotti… - Frontiers in …, 2022‏ - frontiersin.org
Background Glioblastoma (GB) is the most severe form of brain cancer, with a 12-15 month
median survival. Surgical resection, temozolomide (TMZ) treatment, and radiotherapy …

Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma

A Wick, T Kessler, M Platten, C Meisner… - Neuro …, 2020‏ - academic.oup.com
Background O6-methylguanine DNA-methyl transferase (MGMT) promoter methylation
status is predictive for alkylating chemotherapy, but there are non-benefiting subgroups …

Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche

S Chiblak, Z Tang, D Lemke, M Knoll, I Dokic… - JCI …, 2019‏ - pmc.ncbi.nlm.nih.gov
Tumor radioresistance leading to local therapy failure remains a major obstacle for
successful treatment of high-grade glioma. We hypothesized that distinct radiobiological …